Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00482430
Show Display Options
Rank Status Study
1 Completed MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
Conditions: Paranoid Schizophrenia;   Schizophrenia
Interventions: Drug: MK0557;   Drug: Comparator: Placebo (unspecified)

Indicates status has not been verified in more than two years